The effect of betahistine hydrochloride in Méniére's disease.
D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001299:Audiometry; D001621:Betahistine / Q000627:therapeutic use; D005021:Ethylamines / Q000627:therapeutic use*; D005133:Eye Movements; D006320:Hearing Tests; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*; D014724:Vestibular Function Tests
D005021:Ethylamines; D011725:Pyridines; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine